• Return to Headlines

Dexcom Looks to Continue to Trade Above its Annual-High Share Price Today

By James Quinn

Dexcom (NASDAQ:DXCM) traded today at a new 52-week high of $166.16. Approximately 187,000 shares have changed hands today, as compared to an average 30-day volume of 862,000 shares.

Over the past year, Dexcom has traded in a range of $85.76 to $166.16 and is now at $166.16, 94% above that low. In the last five trading sessions, the 50-day moving average (MA) has climbed 2.4% while the 200-day MA has risen 0.6%.

Based on a current price of $166.16, Dexcom is currently 51.1% above its average consensus analyst price target of $81.25. Dexcom shares have support at the 50-day moving average (MA) of $149.57 and additional support at the 200-day MA of $134.81.

DexCom Inc. is a medical device company focused on the design and development of continuous glucose monitoring systems for people with diabetes. The Company has developed a small implantable device that continuously measures glucose levels in subcutaneous tissue just under the skin, and a small external receiver to which the sensor transmits glucose levels at specified intervals.

SmarTrend is monitoring the recent change of momentum in Dexcom. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of Dexcom in search of a potential trend change.

Keywords: 52 week high/lows dexcom

Ticker(s): DXCM